C07D 207/32
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D207/32 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 1,512 US grants and 1,130 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,512
- Published applications
- 1,130
- Assignees
- 769
- Inventors
- 4,517
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 25 | 0 |
| 1977 | 19 | 0 |
| 1978 | 25 | 0 |
| 1979 | 26 | 0 |
| 1980 | 25 | 0 |
| 1981 | 30 | 0 |
| 1982 | 22 | 0 |
| 1983 | 14 | 0 |
| 1984 | 16 | 0 |
| 1985 | 20 | 0 |
| 1986 | 14 | 0 |
| 1987 | 13 | 0 |
| 1988 | 20 | 0 |
| 1989 | 24 | 0 |
| 1990 | 27 | 0 |
| 1991 | 33 | 0 |
| 1992 | 38 | 0 |
| 1993 | 32 | 0 |
| 1994 | 37 | 0 |
| 1995 | 26 | 0 |
| 1996 | 28 | 0 |
| 1997 | 24 | 0 |
| 1998 | 22 | 0 |
| 1999 | 34 | 0 |
| 2000 | 24 | 0 |
| 2001 | 30 | 5 |
| 2002 | 45 | 41 |
| 2003 | 44 | 67 |
| 2004 | 44 | 64 |
| 2005 | 25 | 59 |
| 2006 | 33 | 66 |
| 2007 | 33 | 55 |
| 2008 | 49 | 63 |
| 2009 | 35 | 59 |
| 2010 | 36 | 61 |
| 2011 | 47 | 61 |
| 2012 | 48 | 38 |
| 2013 | 38 | 42 |
| 2014 | 54 | 49 |
| 2015 | 35 | 49 |
| 2016 | 35 | 44 |
| 2017 | 44 | 36 |
| 2018 | 31 | 43 |
| 2019 | 39 | 29 |
| 2020 | 26 | 46 |
| 2021 | 28 | 22 |
| 2022 | 23 | 41 |
| 2023 | 22 | 29 |
| 2024 | 15 | 28 |
| 2025 | 23 | 17 |
| 2026 | 12 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Adduct comprising at least a metal selected from gold, silver and copper and an adduct of a carbon allotrop and a pyrrolic compound25 Aug 2026US 12,715,882 B2
- Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles4 Aug 2026US 12,697,310 B2Montefiore Medical Center
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Polymorphs of phenyl pyrrole aminoguandium salts23 Jun 2026US 12,661,336 B2Synact Pharma APS
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Ophthalmic lens comprising an acrylonitrile compound24 Sep 2026US 2026/0286135 A1Essilor International
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Phosphine ligands and their use in coupling reactions13 Aug 2026US 2026/0234175 A1BASF SE
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Methods for generating high titer helper-free preparations of released recombinant AAV vectors183US 6,566,118 B1Targeted Genetics Corporation · 2003
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Analogs of calicheamicin gamma1I, method of making and using the same149US 5,264,586 AThe Scripps Research Institute · 1993
- Heterocyclic containing biphenyl aP2 inhibitors and method135US 6,548,529 B1Bristol-Myers Squibb Company · 2003